Real-world correlation between therapeutic drug monitoring and clinical outcomes of the antifungal drug posaconazole: a single-center retrospective cohort study
Real-world data demonstrate that TDM enhances the effectiveness of posaconazole in preventing IFD in HSCT patients and moderately reduces treatment costs.
Authors
- Yilei Yang
- Jinjuan Liu
- Qiao-Yan Yi (ORCID: https://orcid.org/0000-0002-3262-0779)
- Haiyan Shi (ORCID: https://orcid.org/0000-0001-9982-244X)
- Yan Li (ORCID: https://orcid.org/0000-0002-5846-7813)
- Xin Huang (ORCID: https://orcid.org/0000-0001-9223-037X)
- Yinping Shi (ORCID: https://orcid.org/0000-0002-4310-653X)
- Dong Lin (ORCID: https://orcid.org/0000-0003-1860-0461)
- Hongmei Wang (ORCID: https://orcid.org/0000-0002-6975-9467)
- Peng Wang (ORCID: https://orcid.org/0000-0001-5184-3129)
- Siwen Li (ORCID: https://orcid.org/0000-0003-0784-134X)
- Zhonghua Dong
Institutions
- Shandong Provincial QianFoShan Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-10
- DOI
- https://doi.org/10.3389/fphar.2025.1592767
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00